IP Verse

Nutrient Composition - EP2374452

The patent EP2374452 was granted to Ajinomoto on Jul 24, 2019. The application was originally filed on Dec 4, 2009 under application number EP09830480A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2374452

AJINOMOTO
Application Number
EP09830480A
Filing Date
Dec 4, 2009
Status
Granted And Under Opposition
Jun 21, 2019
Grant Date
Jul 24, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

FRESENIUS KABI DEUTSCHLANDMar 13, 2020FRESENIUS KABI DEUTSCHLAND -

Patent Citations (24) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONJP2002514575
DESCRIPTIONJPH11508282
DESCRIPTIONWO2005094813
INTERNATIONAL-SEARCH-REPORTJP2001288107
INTERNATIONAL-SEARCH-REPORTJP2006503105
INTERNATIONAL-SEARCH-REPORTJP2006520335
INTERNATIONAL-SEARCH-REPORTJP2008247896
INTERNATIONAL-SEARCH-REPORTJP2008528475
INTERNATIONAL-SEARCH-REPORTJPH0873351
INTERNATIONAL-SEARCH-REPORTJPH11508282
INTERNATIONAL-SEARCH-REPORTWO2005094813
OPPOSITIONEP0747395
OPPOSITIONWO02069964
OPPOSITIONWO2004082402
OPPOSITIONWO2008001086
OPPOSITIONWO2010064714
SEARCHEP0747395
SEARCHWO02069964
SEARCHWO2004026294
SEARCHWO2004082402
SEARCHWO2008001086
SEARCHWO2009157759
SEARCHWO2010002242
SEARCHWO9739749

Non-Patent Literature (NPL) Citations (15) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- AM. J. CLIN. NUTR., (2008), vol. 87, pages 1860 - 1866-
DESCRIPTION- "An overview of regular dialysis treatment in Japan", THE JAPANESE SOCIETY FOR DIALYSIS THERAPY, (20071231), pages 51 - 73-
DESCRIPTION- J. RENAL NUTRITION, (2005), vol. 15, no. 2, pages 253 - 256-
DESCRIPTION- J. RENAL NUTRITION, (2005), vol. 15, no. 3, pages 318 - 331-
DESCRIPTION- KIDNEY INT., (1990), vol. 38, pages 136 - 144-
DESCRIPTION- NEPHROL. DIAL. TRANSPLANT., (2007), vol. 22, no. 12, pages 3561 - 3567-
EXAMINATION- VAN IMMERSEEL FILIP ET AL, "Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease", JOURNAL OF MEDICAL MICROBIOLOGY, CHURCHILL LIVINGSTONE [ETC.], (20100201), vol. 59, no. 2, doi:10.1099/JMM.0.017541-0, ISSN 0022-2615, pages 141 - 143, XP002579463
EXAMINATION- Harry J. Flint ET AL, "Interactions and competition within the microbial community of the human colon: links between diet and health", Environmental Microbiology, GB, (20070501), vol. 9, no. 5, doi:10.1111/j.1462-2920.2007.01281.x, ISSN 1462-2912, pages 1101 - 1111, XP055461048
INTERNATIONAL-SEARCH-REPORT- JOLLY, C.A. ET AL., "Life span is prolonged in food-restricted autoimmune-prone (NZB x NZW)F(l) mice fed a diet enriched with (n-3) fatty acids", J NUTR, (2001), vol. 131, no. 10, pages 2753 - 2760, XP008166556-
INTERNATIONAL-SEARCH-REPORT- SAIFULLAH, A. ET AL., "Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients-a pilot study", NEPHROL DIAL TRANSPLANT, (2007), vol. 22, no. 12, pages 3561 - 3567, XP008166559
INTERNATIONAL-SEARCH-REPORT- LEFKOWITH, J.B. ET AL., "Polyunsaturated fatty acids and renal disease", PROC SOC EXP BIOL MED, (1996), vol. 213, no. 1, pages 13 - 23, XP008166576
OPPOSITION- James W Anderson, "Beneficial effects of soy protein consumption for renal function", Asia Pacific journal of clinical nutrition, HEC Press, Australia, Australia, (20080101), pages 324 - 328, Asia Pacific journal of clinical nutrition, URL: https://pdfs.semanticscholar.org/36f3/82d7e57bf9a0025a645fc1cf80043cda0bc9.pdf, XP055714763-
OPPOSITION- L Azadbakht, Et Al, "Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy", European Journal of Clinical Nutrition, Nature Publishing Group, GB, GB, (20031001), vol. 57, no. 10, doi:10.1038/sj.ejcn.1601688, ISSN 0954-3007, pages 1292 - 1294, XP055714812
OPPOSITION- Hsin-Yi Yang, Jiun-Rong Chen, Le-Shin Chang, "Effects of Soy Protein Hydrolysate on Blood Pressure and Angiotensin-Converting Enzyme Activity in Rats with Chronic Renal Failure", HYPERTENSION RESEARCH. CLINICAL AND EXPERIMENTAL., OSAKA., JP, JP, (20080101), vol. 31, no. 5, doi:10.1291/hypres.31.957, ISSN 0916-9636, pages 957 - 963, XP055714816
OPPOSITION- L. Azadbakht, S. Atabak, A. Esmaillzadeh, "Soy Protein Intake, Cardiorenal Indices, and C-Reactive Protein in Type 2 Diabetes With Nephropathy: A longitudinal randomized clinical trial", DIABETES CARE, AMERICAN DIABETES ASSOCIATION, ALEXANDRIA, VA, US, US, (20080401), vol. 31, no. 4, doi:10.2337/dc07-2065, ISSN 0149-5992, pages 648 - 654, XP055714815

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents